DiaSorin S.p.A. (DIA.MI) is in Healthcare, Diagnostics & Research, based in Italy, listed on Milan. Market cap 3.80B EUR. 52-week range 52.34 to 79.72 EUR. Trailing P/E 28.3. Data as of 2026-10-09.
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which ...